MENU

GNPX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Genprex (GNPX) Ownership - Who owns Genprex?

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Pharmaceuticals Major

Address

3300 Bee Cave Road

Phone

+1 877 774-4679

Employees

13

Web

https://www.genprex.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

6.04M

P/E Ratio

0.08

Total Cash

18.05M

Projected Growth

N/A

Total Debt

279.29K

Revenue

N/A

Risk (Beta)

-1.96

Dividend Yield

N/A

Total Cash/Share

1.65

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

GNPX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for GNPX

A.I. Advisor

published General Information

General Information

a developer of molecular therapies for cancer treatment

Industry Biotechnology

Profile

Details

Industry

Pharmaceuticals Major

Address

3300 Bee Cave Road

Phone

+1 877 774-4679

Employees

13

Web

https://www.genprex.com